Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2023 ▲▼ | Q3 2023 ▲▼ | Change ▲▼ | Q2 2023 ▲▼ | Q3 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Seagen Inc. | 0 | 44,554,162 | +44,554,162 | 0 | 9,452,165 | 54.48% | +9,452,165 |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 0 | 6,702,349 | +6,702,349 | 0 | 153,651 | 0.89% | +153,651 |
| Roivant Sciences Ltd.(ROIV) | 9,428,592 | 11,877,171 | +2,448,579 | 95,040 | 138,725 | 0.80% | +43,685 |
| BeiGene, Ltd.(ONC) | 0 | 11,668,897 | +11,668,897 | 0 | 2,098,885 | 12.10% | +2,098,885 |
| Immunovant, Inc.(IMVT) | 0 | 425,009 | +425,009 | 0 | 16,316 | 0.09% | +16,316 |
| Ultragenyx Pharmaceutical Inc.(RARE) | 783,059 | 1,366,547 | +583,488 | 36,123 | 48,717 | 0.28% | +12,595 |
| Mirati Therapeutics, Inc. | 1,409,784 | 1,409,784 | 0 | 50,935 | 61,410 | 0.35% | +10,475 |
| 2seventy bio, Inc. | 0 | 2,497,526 | +2,497,526 | 0 | 9,790 | 0.06% | +9,790 |
| Kiniksa Pharmaceuticals, Ltd. | 2,809,577 | 2,809,577 | 0 | 39,559 | 48,802 | 0.28% | +9,244 |
| Akero Therapeutics, Inc. | 2,368,378 | 2,368,378 | 0 | 110,580 | 119,793 | 0.69% | +9,213 |
| Arvinas, Inc. | 0 | 413,481 | +413,481 | 0 | 8,121 | 0.05% | +8,121 |
| Taysha Gene Therapies, Inc.(TSHA) | 0 | 2,504,756 | +2,504,756 | 0 | 7,915 | 0.05% | +7,915 |
| Sagimet Biosciences Inc. | 0 | 815,359 | +815,359 | 0 | 7,175 | 0.04% | +7,175 |
| BioMarin Pharmaceutical Inc.(BMRN) | 0 | 3,810,248 | +3,810,248 | 0 | 337,131 | 1.94% | +337,131 |
| Invitae Corporation | 0 | 0 | 0 | 0 | 6,208 | 0.04% | +6,208 |
| Mirum Pharmaceuticals, Inc.(MIRM) | 0 | 190,476 | +190,476 | 0 | 6,019 | 0.03% | +6,019 |
| Tango Therapeutics, Inc.(TNGX) | 750,000 | 750,000 | 0 | 2,490 | 8,445 | 0.05% | +5,955 |
| Morphic Holding, Inc. | 0 | 215,800 | +215,800 | 0 | 4,944 | 0.03% | +4,944 |
| Celcuity Inc.(CELC) | 0 | 535,478 | +535,478 | 0 | 4,894 | 0.03% | +4,894 |
| Neoleukin Therapeutics, Inc. | 0 | 1,221,414 | +1,221,414 | 0 | 4,825 | 0.03% | +4,825 |
| Denali Therapeutics Inc.(DNLI) | 1,455,322 | 2,292,003 | +836,681 | 42,947 | 47,284 | 0.27% | +4,337 |
| IDEAYA Biosciences, Inc.(IDYA) | 1,062,123 | 1,062,123 | 0 | 24,960 | 28,656 | 0.17% | +3,696 |
| Cabaletta Bio, Inc. | 1,594,000 | 1,594,000 | 0 | 20,579 | 24,261 | 0.14% | +3,682 |
| Entrada Therapeutics, Inc. | 4,865,819 | 4,865,819 | 0 | 73,669 | 76,880 | 0.44% | +3,211 |
| Monte Rosa Therapeutics, Inc.(GLUE) | 3,023,951 | 4,916,095 | +1,892,144 | 20,714 | 23,548 | 0.14% | +2,834 |
| Revolution Medicines, Inc.(RVMD) | 2,691,493 | 2,691,493 | 0 | 71,997 | 74,501 | 0.43% | +2,503 |
| Edgewise Therapeutics, Inc.(EWTX) | 500,000 | 1,049,699 | +549,699 | 3,875 | 6,015 | 0.03% | +2,140 |
| Insmed Incorporated(INSM) | 343,000 | 343,000 | 0 | 7,237 | 8,661 | 0.05% | +1,423 |
| HOOKIPA Pharma Inc. | 4,425,535 | 8,065,398 | +3,639,863 | 3,894 | 4,968 | 0.03% | +1,074 |
| Praxis Precision Medicines, Inc. | 1,879,915 | 1,879,915 | 0 | 2,162 | 3,215 | 0.02% | +1,053 |
| Cogent Biosciences, Inc.(COGT) | 979,600 | 1,292,966 | +313,366 | 11,598 | 12,606 | 0.07% | +1,008 |
| KALA BIO, Inc. | 116,213 | 266,613 | +150,400 | 1,696 | 2,373 | 0.01% | +677 |
| Perspective Therapeutics, Inc. | 2,319,286 | 7,639,703 | +5,320,417 | 1,549 | 2,091 | 0.01% | +542 |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 0 | 12,710,818 | +12,710,818 | 0 | 89,993 | 0.52% | +89,993 |
| Alector, Inc. | 964,851 | 964,851 | 0 | 5,799 | 6,252 | 0.04% | +453 |
| Design Therapeutics, Inc.(DSGN) | 500,000 | 1,500,000 | +1,000,000 | 3,150 | 3,540 | 0.02% | +390 |
| Day One Biopharmaceuticals, Inc. COM | 1,000,000 | 1,000,000 | 0 | 11,940 | 12,270 | 0.07% | +330 |
| Immatics N.V.(IMTX) | 5,640,816 | 5,640,816 | 0 | 65,095 | 65,321 | 0.38% | +226 |
| TScan Therapeutics, Inc. | 2,784,792 | 2,784,792 | 0 | 6,962 | 7,129 | 0.04% | +167 |
| Vaxcyte, Inc.(PCVX) | 48,885 | 48,885 | 0 | 2,441 | 2,492 | 0.01% | +51 |
| Surrozen, Inc. | 833,333 | 833,333 | 0 | 46 | 34 | 0.00% | -12 |
| PMV Pharmaceuticals, Inc. | 322,024 | 322,024 | 0 | 2,016 | 1,977 | 0.01% | -39 |
| Genetron Holdings Limited | 455,306 | 455,306 | 0 | 423 | 370 | 0.00% | -54 |
| Achilles Therapeutics plc | 2,557,149 | 2,557,149 | 0 | 2,417 | 2,327 | 0.01% | -90 |
| Foghorn Therapeutics Inc. | 45,027 | 45,027 | 0 | 317 | 225 | 0.00% | -92 |
| Protara Therapeutics, Inc. | 199,671 | 199,671 | 0 | 477 | 333 | 0.00% | -144 |
| Krystal Biotech, Inc.(KRYS) | 169,934 | 169,934 | 0 | 19,950 | 19,712 | 0.11% | -238 |
| Vincerx Pharma, Inc. | 225,579 | 0 | -225,579 | 293 | 0 | — | -293 |
| iTeos Therapeutics, Inc. | 150,346 | 150,346 | 0 | 1,991 | 1,646 | 0.01% | -344 |
| Natera, Inc.(NTRA) | 100,000 | 100,000 | 0 | 4,866 | 4,425 | 0.03% | -441 |
| Aligos Therapeutics, Inc. | 2,076,400 | 2,076,400 | 0 | 2,016 | 1,551 | 0.01% | -465 |
| Xencor, Inc.(XNCR) | 123,127 | 123,127 | 0 | 3,074 | 2,481 | 0.01% | -593 |
| Nkarta, Inc. | 271,329 | 0 | -271,329 | 594 | 0 | — | -594 |
| Vor Biopharma Inc.(VOR) | 633,848 | 633,848 | 0 | 1,959 | 1,344 | 0.01% | -615 |
| bluebird bio, Inc. | 2,499,715 | 2,499,715 | 0 | 8,224 | 7,599 | 0.04% | -625 |
| FibroGen, Inc. | 0 | 0 | 0 | 0 | 0 | — | 0 |
| Talis Biomedical Corporation | 7,624,835 | 508,323 | -7,116,512 | 3,660 | 2,933 | 0.02% | -727 |
| Instil Bio, Inc. | 5,273,789 | 4,704,395 | -569,394 | 2,906 | 2,013 | 0.01% | -892 |
| Gracell Biotechnologies Inc. | 1,000,000 | 1,000,000 | 0 | 3,810 | 2,880 | 0.02% | -930 |
| Heron Therapeutics, Inc. | 8,131,678 | 8,131,678 | 0 | 9,433 | 8,376 | 0.05% | -1,057 |
| Century Therapeutics, Inc. | 1,149,340 | 1,149,340 | 0 | 3,632 | 2,299 | 0.01% | -1,333 |
| Aeglea BioTherapeutics, Inc. | 3,410,106 | 0 | -3,410,106 | 1,536 | 0 | — | -1,536 |
| Adaptimmune Therapeutics plc | 10,969,282 | 10,969,282 | 0 | 10,147 | 8,556 | 0.05% | -1,591 |
| Affimed N.V. | 6,596,830 | 4,448,644 | -2,148,186 | 3,946 | 2,126 | 0.01% | -1,820 |
| Compass Therapeutics, Inc. | 1,557,630 | 1,557,630 | 0 | 4,953 | 3,069 | 0.02% | -1,885 |
| Aadi Bioscience, Inc. | 989,928 | 989,928 | 0 | 6,771 | 4,791 | 0.03% | -1,980 |
| Leap Therapeutics, Inc. | 1,172,175 | 1,172,175 | 0 | 3,669 | 1,618 | 0.01% | -2,051 |
| Mersana Therapeutics, Inc. | 1,086,115 | 1,086,115 | 0 | 3,573 | 1,379 | 0.01% | -2,194 |
| Vera Therapeutics, Inc.(VERA) | 146,464 | 0 | -146,464 | 2,351 | 0 | — | -2,351 |
| Atreca, Inc. | 3,532,760 | 3,532,760 | 0 | 3,462 | 922 | 0.01% | -2,540 |
| IGM Biosciences, Inc. | 0 | 3,157,764 | +3,157,764 | 0 | 26,367 | 0.15% | +26,367 |
| Opthea Limited | 2,691,391 | 2,690,891 | -500 | 7,536 | 4,688 | 0.03% | -2,848 |
| Athira Pharma, Inc. | 3,153,807 | 3,153,807 | 0 | 9,304 | 6,371 | 0.04% | -2,933 |
| Sera Prognostics, Inc. | 1,777,435 | 1,515,342 | -262,093 | 5,857 | 2,819 | 0.02% | -3,038 |
| Neoleukin Therapeutics, Inc. | 3,821,740 | 0 | -3,821,740 | 3,172 | 0 | — | -3,172 |
| Xenon Pharmaceuticals Inc.(XENE) | 751,639 | 751,639 | 0 | 28,938 | 25,676 | 0.15% | -3,262 |
| Geron Corporation(GERN) | 3,061,224 | 3,061,224 | 0 | 9,827 | 6,490 | 0.04% | -3,337 |
| Aravive, Inc. | 3,261,224 | 0 | -3,261,224 | 4,109 | 0 | — | -4,109 |
| Sana Biotechnology, Inc.(SANA) | 2,000,000 | 2,000,000 | 0 | 11,920 | 7,740 | 0.04% | -4,180 |
| Bicycle Therapeutics plc | 843,814 | 843,814 | 0 | 21,534 | 16,952 | 0.10% | -4,582 |
| Invitae Corporation | 0 | 0 | 0 | 135,000 | 130,373 | 0.75% | -4,627 |
| Mereo BioPharma Group PLC | 3,554,979 | 0 | -3,554,979 | 4,693 | 0 | — | -4,693 |
| MacroGenics, Inc. | 892,579 | 0 | -892,579 | 4,775 | 0 | — | -4,775 |
| Relay Therapeutics, Inc.(RLAY) | 1,160,117 | 1,160,117 | 0 | 14,571 | 9,757 | 0.06% | -4,814 |
| Prime Medicine, Inc. | 1,028,466 | 1,028,466 | 0 | 15,067 | 9,812 | 0.06% | -5,255 |
| Pacific Biosciences of California, Inc. | 1,127,782 | 1,127,782 | 0 | 15,000 | 9,417 | 0.05% | -5,583 |
| ARS Pharmaceuticals, Inc. | 2,006,451 | 2,006,451 | 0 | 13,443 | 7,584 | 0.04% | -5,859 |
| Aerovate Therapeutics, Inc. | 1,963,479 | 1,963,479 | 0 | 33,674 | 26,644 | 0.15% | -7,029 |
| Verve Therapeutics, Inc. | 1,416,530 | 1,416,530 | 0 | 26,560 | 18,783 | 0.11% | -7,777 |
| Avidity Biosciences, Inc. | 0 | 166,347 | +166,347 | 0 | 1,061 | 0.01% | +1,061 |
| Allogene Therapeutics, Inc. | 1,576,901 | 0 | -1,576,901 | 7,837 | 0 | — | -7,837 |
| DBV Technologies S.A. | 14,614,264 | 14,614,264 | 0 | 27,767 | 19,875 | 0.11% | -7,892 |
| Fate Therapeutics, Inc. | 1,671,717 | 0 | -1,671,717 | 7,957 | 0 | — | -7,957 |
| Nurix Therapeutics, Inc.(NRIX) | 3,882,125 | 3,882,125 | 0 | 38,782 | 30,514 | 0.18% | -8,269 |
| POINT Biopharma Global Inc. | 1,169,103 | 249,968 | -919,135 | 10,592 | 1,667 | 0.01% | -8,925 |
| Invitae Corporation | 8,881,104 | 1,764,546 | -7,116,558 | 10,036 | 1,068 | 0.01% | -8,968 |
| SpringWorks Therapeutics, Inc. | 2,999,846 | 2,999,846 | 0 | 78,656 | 69,356 | 0.40% | -9,300 |
| Verastem, Inc. | 1,336,485 | 0 | -1,336,485 | 9,943 | 0 | — | -9,943 |
| Summit Therapeutics Inc.(SMMT) | 6,304,705 | 3,140,473 | -3,164,232 | 15,825 | 5,873 | 0.03% | -9,952 |
| AbCellera Biologics Inc.(ABCL) | 16,450,180 | 20,763,323 | +4,313,143 | 106,268 | 95,511 | 0.55% | -10,757 |